杨学宁, 吴一龙. 实体瘤治疗疗效评价标准-RECIST[J]. 循证医学, 2004, 4(2): 85-90. DOI: 10.3969/j.issn.1671-5144.2004.02.007
    引用本文: 杨学宁, 吴一龙. 实体瘤治疗疗效评价标准-RECIST[J]. 循证医学, 2004, 4(2): 85-90. DOI: 10.3969/j.issn.1671-5144.2004.02.007
    RECIST-New guidelines to evaluate the response to treatment in solid tumors[J]. Journal of Evidence-Based Medicine, 2004, 4(2): 85-90. DOI: 10.3969/j.issn.1671-5144.2004.02.007
    Citation: RECIST-New guidelines to evaluate the response to treatment in solid tumors[J]. Journal of Evidence-Based Medicine, 2004, 4(2): 85-90. DOI: 10.3969/j.issn.1671-5144.2004.02.007

    实体瘤治疗疗效评价标准-RECIST

    RECIST-New guidelines to evaluate the response to treatment in solid tumors

    • 摘要: 实体瘤治疗疗效评价标准的发展已有近40年的历史.RECIST已成为目前国际肿瘤界采用的新标准.与WHO标准相比,RECIST更强调测量的易重复性和易追踪.RECIST可以简要概括如下:以肿瘤最长径(需≥20mim)为测量基线.治疗后,肿瘤最长径缩小≥30%为部分缓解,增大≥20%则为疾病进展.建议国内肿瘤界应尽快转向以RECIST对肿瘤进行测量和评价的体系.

       

    /

    返回文章
    返回